MDI improves patient outcomes and reduces healthcare costs by enabling providers to deliver data-driven polypharmacy management (MTM) at scale. Its AI-powered platform personalizes drug therapy, recording and analyzing medication data to ensure treatment efficacy, safety, and early detection of potential issues. While MTM is a proven life-saving practice, it has historically been costly and limited to only the highest-risk patients. MDI digitizes and automates the process, making MTM accessible to all populations. The company is already partnering with leading providers and payers in Israel and the US across diverse use-cases.